UK regulator MHRA says it found the counterfeit weight loss products in what it called a filthy warehouse in Birmingham.
Recap by typeshit. Post by @chemistdruggist on Instagram.
Strive Specialties failed to revive its suit over GLP-1 competition. Novo still faces soft 2026 forecasts and an exploratory CagriSema analysis in women.
Reports say RFK Jr. backs an interim path for specialty compounding, while the FDA lists BPC-157 as a possible safety risk and doctors cite thin human evidence.
Belga reports the number of seized weight loss drugs in Belgium went up again, with officials concerned about an unofficial parallel market.
Clinics took about 60% of supply, and one Seoul clinic got more Mounjaro than 174 hospitals combined. The health ministry warns of sanctions and criminal referrals.
The endocrinologist calls the recording a proud career moment and asks followers to set aside an hour for the class. The topic isn't stated.
An explainer on the oral version of Wegovy and the weight loss results reported for it. Only the headline is available, so check the source for details.
Loading…